Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Watterson

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Plos Pathogens|January 13, 2017
Fighting Ebola: A Window for Vaccine Re-evaluation?Keith J Chappell, Daniel Watterson
The Journal of General Virology|September 30, 2011
Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan bindingDaniel Watterson, Bostjan Kobe, Paul R Young
Antiviral Research|March 6, 2016
The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor designDaniel Watterson, Naphak Modhiran, Paul R Young
Science Translational Medicine|December 18, 2015
Response to comment on "Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity" and "Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination"Katryn J Stacey, Daniel Watterson, Naphak Modhiran, et al.
Journal of Virology|December 8, 2017
The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane FusionImogen M Bermingham, Keith J Chappell, Daniel Watterson, et al.
Biosensors & Bioelectronics|October 7, 2014
Evaluation of direct versus multi-layer passivation and capture chemistries for nanoparticle-based biosensor applicationsK C Sanjaya, Andrea Ranzoni, Daniel Watterson, et al.
Vaccines|January 12, 2021
The Next Generation of Influenza Vaccines: Towards a Universal SolutionChristopher L D McMillan, Paul R Young, Daniel Watterson, et al.
The Journal of Infectious Diseases|April 1, 2025
Transcriptome Analysis of Monocytes Treated with Dengue NS1 Revealed a Shift in Transcripts Involving in Self-Propagated Proinflammation and Antiviral ResponsesKhwankhao Saisingha, Tuksin Jearanaiwitayakul, Daniel Watterson, et al.
Advances in Experimental Medicine and Biology|May 31, 2018
Plugging the Leak in Dengue ShockDaniel Watterson, Naphak Modhiran, David A Muller, et al.
Immunology and Cell Biology|February 22, 2017
Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6Naphak Modhiran, Daniel Watterson, Antje Blumenthal, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Plos Pathogens|January 13, 2017
Fighting Ebola: A Window for Vaccine Re-evaluation?Keith J Chappell, Daniel Watterson
The Journal of General Virology|September 30, 2011
Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan bindingDaniel Watterson, Bostjan Kobe, Paul R Young
Antiviral Research|March 6, 2016
The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor designDaniel Watterson, Naphak Modhiran, Paul R Young
Science Translational Medicine|December 18, 2015
Response to comment on "Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity" and "Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination"Katryn J Stacey, Daniel Watterson, Naphak Modhiran, et al.
Journal of Virology|December 8, 2017
The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane FusionImogen M Bermingham, Keith J Chappell, Daniel Watterson, et al.
Biosensors & Bioelectronics|October 7, 2014
Evaluation of direct versus multi-layer passivation and capture chemistries for nanoparticle-based biosensor applicationsK C Sanjaya, Andrea Ranzoni, Daniel Watterson, et al.
Vaccines|January 12, 2021
The Next Generation of Influenza Vaccines: Towards a Universal SolutionChristopher L D McMillan, Paul R Young, Daniel Watterson, et al.
The Journal of Infectious Diseases|April 1, 2025
Transcriptome Analysis of Monocytes Treated with Dengue NS1 Revealed a Shift in Transcripts Involving in Self-Propagated Proinflammation and Antiviral ResponsesKhwankhao Saisingha, Tuksin Jearanaiwitayakul, Daniel Watterson, et al.
Advances in Experimental Medicine and Biology|May 31, 2018
Plugging the Leak in Dengue ShockDaniel Watterson, Naphak Modhiran, David A Muller, et al.
Immunology and Cell Biology|February 22, 2017
Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6Naphak Modhiran, Daniel Watterson, Antje Blumenthal, et al.
Pageof 12